CTRI/2009/091/000626已完成3 期
A single centre, randomized, double blinded, controlled experimental gingivitis model to compare the efficacy of 2 product formulations against a regular toothpaste.
Smile Care Clinic Pvt Ltd0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Ability to understand and sign a consent form prior to the recruitment on the study.
- •2. Male and female subjects 18 -45 years
- •3. Patients with moderate gingivitis MGI average ≥2 but showing no signs of periodontitis (absence of periodontal pockets )
- •4. Minimum 24 scorable, non restored natural teeth.
- •5. Good general and oral health
- •6. Ability and willingness of subjects to follow the study procedures(refraining from all oral hygiene method except study product use for 3 weeks,) attend all scheduled visits and successfully complete the study
排除标准
- •1. Periodontitis, active unfilled caries , heavy stains
- •2. Compulsive paan or tobacco consumers
- •3. Orthodontic bands, dentures
- •4. Allergy to any dental or oral hygiene products
- •5. Medical conditions that would affect oral health eg. Diabetes,
- •6. Females who are pregnant or nursing or use contraceptive pills.
- •7. Recent use of anti-inflammatory or antibiotic medicaments.
- •8. Participating in any other study.
研究者
相似试验
撤回
1 期
A single centre, double blind, randomised, parallel group, single dose signal study of R-107 in participants with DSM-5 specific phobiaSpecific phobia to spidersMental Health - Other mental health disordersACTRN12618001381279Douglas Pharmaceuticals Ltd12
尚未招募
2 期
A single centre, double blind, randomised, parallel group study to explore the efficacy and tolerability of intranasal fluticasone propionate compared with placebo delivered by the OptiNose device in adult subjects with chronic rhinosinusitis.chronic rhinosinusitis10046304NL-OMON30750OptiNose UK Ltd40
尚未招募
1 期
study to understand bio availability wockhardtâ??s wosulin® 30/70 and actraphane 30 , in healthysubjectsCTRI/2020/04/024787Wockhardt Bio AG
已完成
1 期
A single and multiple dose safety and tolerability study of oral ketamine in healthy volunteer and patients with a history of depression or anxiety.Mental Health - DepressionMental Health - AnxietyDepressionAnxietyACTRN12616001351404Zenith Technology Corp Ltd43
已完成
1 期
A phase 1 clinical trial to evaluate the safety, pharmacokinetics/pharmacodynamics, and immunogenicity of single and multiple ascending subcutaneous doses of RS2102 in healthy adult subjectsInflammatory and Immune System - Autoimmune diseasesSystemic lupus erythematosusACTRN12621001161819Atridia Pty Ltd56